These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16187692)

  • 1. Calcium sensitization as a pharmacological target in vascular smooth-muscle regulation.
    Christ G; Wingard C
    Curr Opin Investig Drugs; 2005 Sep; 6(9):920-33. PubMed ID: 16187692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rho/Rho kinase signal transduction pathway in cardiovascular disease and cardiovascular remodeling].
    Jalil J; Lavandero S; Chiong M; Ocaranza MP
    Rev Esp Cardiol; 2005 Aug; 58(8):951-61. PubMed ID: 16053829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II up-regulates the leukemia-associated Rho guanine nucleotide exchange factor (RhoGEF), a regulator of G protein signaling domain-containing RhoGEF, in vascular smooth muscle cells.
    Ying Z; Jin L; Palmer T; Webb RC
    Mol Pharmacol; 2006 Mar; 69(3):932-40. PubMed ID: 16354763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells.
    Yoshioka K; Sugimoto N; Takuwa N; Takuwa Y
    Mol Pharmacol; 2007 Mar; 71(3):912-20. PubMed ID: 17179444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Novel mechanisms for increasing Ca2+ sensitivity of contractile apparatus in smooth muscle].
    Todoroki-Ikeda N; Mogami K; Ohmura M; Yoshimoto Y; Matsuzaki M; Oka M; Kobayashi S
    Masui; 1998 May; 47(5):530-40. PubMed ID: 9621661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol primes vascular smooth muscle to induce Ca2 sensitization mediated by a sphingosylphosphorylcholine-Rho-kinase pathway: possible role for membrane raft.
    Morikage N; Kishi H; Sato M; Guo F; Shirao S; Yano T; Soma M; Hamano K; Esato K; Kobayashi S
    Circ Res; 2006 Aug; 99(3):299-306. PubMed ID: 16825579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho kinase inhibitors as potential therapeutic agents for cardiovascular diseases.
    Hu E; Lee D
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1065-75. PubMed ID: 14582450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Rho and Rho-kinase in the treatment of cardiovascular disease.
    Budzyn K; Marley PD; Sobey CG
    Trends Pharmacol Sci; 2006 Feb; 27(2):97-104. PubMed ID: 16376997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependence of proliferating dedifferentiated vascular smooth muscle contraction on Rho-Rho kinase system.
    Nishimura J; Bi D; Kanaide H
    Trends Cardiovasc Med; 2006 May; 16(4):124-8. PubMed ID: 16713535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for Rho kinase in vascular contraction evoked by sodium fluoride.
    Jeon SB; Jin F; Kim JI; Kim SH; Suk K; Chae SC; Jun JE; Park WH; Kim IK
    Biochem Biophys Res Commun; 2006 Apr; 343(1):27-33. PubMed ID: 16527249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brazilein-induced contraction of rat arterial smooth muscle involves activation of Ca2+ entry and ROK, ERK pathways.
    Shen J; Yip S; Wang Z; Wang W; Xing D; Du L
    Eur J Pharmacol; 2008 Feb; 580(3):366-71. PubMed ID: 18177858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Rho kinase and protein kinase C in carbachol-induced calcium sensitization in beta-escin skinned rat and guinea-pig bladders.
    Durlu-Kandilci NT; Brading AF
    Br J Pharmacol; 2006 Jun; 148(3):376-84. PubMed ID: 16565731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho signaling: agonist stimulation and depolarization come together.
    Brozovich FV
    Circ Res; 2003 Sep; 93(6):481-3. PubMed ID: 14500329
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular signaling through G-protein-coupled receptors and the control of intracellular calcium in myometrium.
    Sanborn BM; Ku CY; Shlykov S; Babich L
    J Soc Gynecol Investig; 2005 Oct; 12(7):479-87. PubMed ID: 16202924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diguanosine pentaphosphate: an endogenous activator of Rho-kinase possibly involved in blood pressure regulation.
    Tölle M; Giebing G; Tietge UJ; Jankowski J; Jankowski V; Henning L; Hörl MP; Weiss W; Zidek W; van der Giet M
    J Hypertens; 2006 Oct; 24(10):1991-2000. PubMed ID: 16957559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ca2+-independent, inhibitory effects of cyclic adenosine 5'-monophosphate on Ca2+ regulation of phosphoinositide 3-kinase C2alpha, Rho, and myosin phosphatase in vascular smooth muscle.
    Azam MA; Yoshioka K; Ohkura S; Takuwa N; Sugimoto N; Sato K; Takuwa Y
    J Pharmacol Exp Ther; 2007 Feb; 320(2):907-16. PubMed ID: 17110524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of rho kinase in the ouabain-induced contractions of the rat renal arteries.
    Ark M; Kubat H; Beydaği H; Ergenoğlu T; Songu-Mize E
    Biochem Biophys Res Commun; 2006 Feb; 340(2):417-21. PubMed ID: 16375858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights.
    Jin L; Burnett AL
    Clin Sci (Lond); 2006 Feb; 110(2):153-65. PubMed ID: 16411892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Rho-kinase dependency of full and partial muscarinic receptor agonists in airway smooth muscle contraction.
    Schaafsma D; Boterman M; de Jong AM; Hovens I; Penninks JM; Nelemans SA; Meurs H; Zaagsma J
    Br J Pharmacol; 2006 Apr; 147(7):737-43. PubMed ID: 16432505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle.
    Morgado M; Cairrão E; Santos-Silva AJ; Verde I
    Cell Mol Life Sci; 2012 Jan; 69(2):247-66. PubMed ID: 21947498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.